Stock Events

Stock Events

Twist Bioscience 

$46.81
259
+$5.74+13.98% Today

Statistics

Day High
47.74
Day Low
42.64
52W High
54.74
52W Low
23.3
Volume
2,720,939
Avg. Volume
1,438,626
Mkt Cap
2.86B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.71
-0.37
-0.02
0.33
Expected EPS
-0.432778
Actual EPS
N/A

Financials

-20.63%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
753.14MRevenue
-155.34MNet Income

Analyst Ratings

$43.00Average Price Target
The highest estimate is 50.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TWST. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Twist Bioscience's synthetic DNA products.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies, competing with Twist Bioscience in the genomics and DNA sequencing market.
Agenus
AGEN
Mkt Cap126.5M
Agenus is involved in immuno-oncology, a field that relies on synthetic biology and genomics, areas where Twist Bioscience operates.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is focused on gene editing, a sector that directly competes with Twist Bioscience's synthetic DNA for research and therapeutic applications.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the gene editing space, competing with Twist Bioscience in the development of genomic tools and therapies.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is another key player in the CRISPR/Cas9 gene editing technology, competing with Twist Bioscience in the genomic medicine field.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics focuses on genomic medicine, including gene editing and gene therapy, areas where Twist Bioscience's synthetic DNA products are relevant.
Adaptive Biotechnologies
ADPT
Mkt Cap2.64B
Adaptive Biotechnologies is engaged in the immune-driven medicine space, leveraging genomics and competing with Twist Bioscience in the use of synthetic DNA for immune system understanding.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics provides tools for genomic analysis, competing in the broader genomics market where Twist Bioscience offers synthetic DNA solutions.

About

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Show more...
CEO
Dr. Emily Marine Leproust Ph.D.
Employees
923
Country
US
ISIN
US90184D1000

Listings

MI
IT
1TWST.MI
BOATS
BOATS
TWST.BOATS
XNAS
US
TWST
F
DE
0ME.F

0 Comments

Share your thoughts

FAQ

What is Twist Bioscience stock price today?▼
The current price of TWST is $46.81 USD — it has increased by +13.98% in the past 24 hours. Watch Twist Bioscience stock price performance more closely on the chart.
What is Twist Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Twist Bioscience stocks are traded under the ticker TWST.
Is Twist Bioscience stock price growing?▼
TWST stock has risen by +10.24% compared to the previous week, the month change is a +44.52% rise, over the last year Twist Bioscience has showed a -10.62% decrease.
What is Twist Bioscience market cap?▼
Today Twist Bioscience has the market capitalization of 2.86B
When is the next Twist Bioscience earnings date?▼
Twist Bioscience is going to release the next earnings report on April 30, 2026.
What were Twist Bioscience earnings last quarter?▼
TWST earnings for the last quarter are -0.5 USD per share, whereas the estimation was -0.42 USD resulting in a -17.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Twist Bioscience revenue for the last year?▼
Twist Bioscience revenue for the last year amounts to 753.14M USD.
What is Twist Bioscience net income for the last year?▼
TWST net income for the last year is -155.34M USD.
How many employees does Twist Bioscience have?▼
As of February 02, 2026, the company has 923 employees.
In which sector is Twist Bioscience located?▼
Twist Bioscience operates in the Health Care sector.
When did Twist Bioscience complete a stock split?▼
Twist Bioscience has not had any recent stock splits.
Where is Twist Bioscience headquartered?▼
Twist Bioscience is headquartered in South San Francisco, US.